Pregnancy assay kit P123H

Streptococcus Bfor cervical cellsfor real-time PCR

According to statistics, 10%~30% of pregnant women will infect group B streptococcus, 40%~70% of which will transmit GBS to the next generation during the birth process. Group B streptococcal infection can cause neonatal sepsis, meningitis, and pneumonia, and the mortality rate is very high. It is currently one of the most important pathogens causing neonatal infections. The kit is used for in vitro qualitative detection of group B streptococci in genital secretions and rectal secretions samples. It is suitable for pregnant women who are 34 to 37 weeks of gestation. The test result of this kit is for the auxiliary diagnosis of GBS. It is for clinical reference only and cannot be used as the basis for diagnosis or exclusion of cases. Accurate performance: Qualitative detection of Group B Streptococcus (GBS) in genital secretions and rectal secretions samples of pregnant women between 34-37 weeks of gestation. High Sensitivity: The limit of detection is up to 500 copies/mL Internal Control: The use of internal control system in the kit can effectively prevent false negative results User-friendly: Widely applicable in instruments with FAM, VIC (HEX) fluorescence channels More Accessible: CE marked, accessible for more counties High Precision: The coefficient of variation (CV%) of Ct value should be no more than 5%